ZTEK_OUT_1 [2025-04-28 13:43:03 -0400] 5011 Bytes | 1347 tokens | Cum: 1347 tkns (16.84% of 8k)
==========================================================================

Listen up, partner—it's 1:43 PM on Mon Apr 28, 2025, and I’m revved up about Zentek (ZTEK), climbing from $1.29 to $1.52. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: Zentek (ZTEK)
IPO: 2012-03-29 (13 Years Ago)
Market Cap: $119,958,167
Shares Outstanding: 104,310,000
Exchange: XNAS
Description: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Here’s a list of headlines for Zentek:

Apr-23-25 07:30AM - Zentek Provides Update on ~$1.1?Million Innovative Solutions Canada Contract to Develop an Avian Influenza Countermeasure (H5N1) Using its Multivalent Aptamer Technology
Apr-17-25 04:05PM - Zentek Announces Sale of Corporate Court Office
Apr-16-25 08:00AM - Zentek Completes Testing of ZenARMOR(TM) Corrosion Prevention Technology as part of its Innovative Solutions Canada Testing Stream and Announces a New Collaboration with Jazeera Paints Company
Apr-14-25 08:00AM - Zentek Announce Strategic Partnership with Filtration Solutions Industrial Co. to Manufacture and Distribute Graphene-Enhanced HVAC Filters
Apr-09-25 01:15PM - Zentek Announces Closing of $2,000,000 Non-Brokered Private Placement of Debenture Units
Mar-28-25 01:08PM - Graphite Miners News For The Month Of March 2025
Mar-21-25 04:15PM - Zentek Announces Results of Canada Revenue Agency Audit
Mar-12-25 07:30AM - Zentek Completes Shelf-Life Efficacy Testing for ZenGUARD(TM) Enhanced Air Filter Commercialization
Mar-03-25 06:28PM - Zentek Announces US$30 Million At-The-Market Offering in the United States
Feb-15-25 10:35AM - Zenteks Albany Graphite provides update on thermal purification results
Feb-14-25 10:20AM - Zentek Subsidiary Albany Graphite Corp. Provides Update on Thermal Purification Testwork Results
Jan-17-25 08:00AM - Zentek Provides Update on ZenGUARD(TM) Enhanced Air Filters for the Canadian Market
Jan-08-25 09:10AM - Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity
Dec-12-24 08:30AM - Zentek Provides Update on International Opportunities
Dec-09-24 11:30AM - Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
Nov-27-24 08:45AM - ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
Nov-06-24 07:15AM - Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
Oct-31-24 07:15AM - Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters
Oct-17-24 08:00AM - Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
Sep-26-24 06:25PM - Zentek Announces Voting Results of Annual and Special Meeting
Sep-13-24 04:45PM - Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Aug-19-24 12:52PM - Zentek Announces Closing of Non-Brokered Private Placement of Units

Prior AI Reports for ZTEK:
1. 2025-03-20 – Score: 82 – Target: 1.3300 – Highs: 1.1700 / 1.1800 / 1.21
zenteks-dramatic-sales-surge-fuels-market-optimism

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2022-10-24T09:37:02Z - Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Zentek (ZTEK).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

ZTEK_OUT_3 [2025-04-28 13:43:04 -0400] 1018 Bytes | 298 tokens | Cum: 1647 tkns (20.59% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-23T11:31:35Z - Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Inf...
A2 - 2025-04-23T07:33:01Z - Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Inf...
A3 - 2025-04-23T11:47:43Z - Zentek Ltd.: Zentek Provides Update on ~$1.1?Million Innovative Solutions Canada Contract to Develop...
A4 - 2025-04-23T11:44:28Z - Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Inf...
A5 - 2025-04-23T11:44:28Z - Zentek (ZTEK) Provides Update on $1.1M Innovative Solutions Canada Contract...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ZTEK_OUT_5 [2025-04-28 13:43:05 -0400] 1141 Bytes | 333 tokens | Cum: 1982 tkns (24.77% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
**Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Influenza Countermeasure (H5N1) Using its Multivalent Aptamer Technology**Date: 2025-04-23Source: {'uri': 'eagletribune.com', 'dataType': 'news', 'title': 'Eagle-Tribune'}URL: https://www.eagletribune.com/region/zentek-provides-update-on-1-1-million-innovative-solutions-canada-contract-to-develop-an-avian/article_a5bbf985-a739-5c4a-b1f5-0f4d75094634.htmlGUELPH, ON / ACCESS Newswire / April 23, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), is pleased to announce that it has completed the first phase of the Innovative Solutions Canada Testing Stream contract by delivering a lead candidate countermeasure for highly pathogenic avian influenza (HPAI) A(H5N1) and has now moved to the testing phase of the project.

Highlights:

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ZTEK_OUT_7 [2025-04-28 13:43:05 -0400] 238 Bytes | 59 tokens | Cum: 2043 tkns (25.54% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ZTEK_OUT_9 [2025-04-28 13:43:13 -0400] 4870 Bytes | 1182 tokens | Cum: 3227 tkns (40.34% of 8k)
==========================================================================

This is our set of metrics for Zentek.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+-----------------------+
| Volume: 144,323 | Perf Month: 27.35% | Option/Short: No / Yes | Sales Y/Y TTM: 88.10% |
+--------------------+-----------------------+------------------------+-----------------------+
| Avg Volume: 33.00K | Perf Quarter: 30.70% | Short Float: 0.07% | ROE: -54.98% |
+--------------------+-----------------------+------------------------+-----------------------+
| Rel Volume: 6.97 | Index: - | Short Ratio: 2.12 | ROI: -68.22% |
+--------------------+-----------------------+------------------------+-----------------------+
| RSI (14): 74.63 | Market Cap: 155.42M | Short Interest: 0.07M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+-----------------------+
| ATR (14): 0.11 | Shs Outstand: 104.11M | Beta: 0.78 | EPS Surprise: - |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA20: 33.28% | Shs Float: 98.34M | Sales Q/Q: 195.82% | P/E: - |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA50: 40.85% | Inst Own: 1.66% | Sales past 5Y: -34.88% | Earnings: - |
+--------------------+-----------------------+------------------------+-----------------------+
| SMA200: 53.46% | Insider Own: 5.72% | Employees: 25 | |
+--------------------+-----------------------+------------------------+-----------------------+
| Perf Week: 36.07% | Insider Trans: 0.00% | Debt/Eq: 0.05 | |
+--------------------+-----------------------+------------------------+-----------------------+

The next section covers any insider trading by Zentek officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.5239
Average Volume: 29285.55
30-Day High: 1.5239
30-Day Low: 0.9786
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Zentek (ZTEK).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Zentek.

2) MARKET_SCORE[]
This conversation was initiated because ZTEK is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for ZTEK.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, ZTEK could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect ZTEK to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Zentek.

11) ETHICAL_RATING[]
Rate Zentek’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Zentek.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

ZTEK_IN_11 [2025-04-28 13:43:13 -0400] 126 Bytes | 29 tokens | Cum: 3471 tkns (43.39% of 8k)
==========================================================================

====================================
[2025-04-28 13:43:13] # Analysis Completed
Elapsed Time: 10.80 seconds